Wells Fargo Maintains GeneDx Holdings(WGS.US) With Hold Rating, Raises Target Price to $75

富國集團維持GeneDx Holdings(WGS.US)持有評級，上調目標價至75美元

moomoo資訊 · 10/30 06:31 · 評級/大行評級

Wells Fargo analyst Brandon Couillard maintains $GeneDx Holdings (WGS.US)$ with a hold rating, and adjusts the target price from $66 to $75.

According to TipRanks data, the analyst has a success rate of 61.9% and a total average return of 18.0% over the past year.

AnalystRecentRatingAutoNews_83176336882815_20241029_a217f42d556d60e2dbb6108a6579d67f288a3b34_1730241055498533_mm_en

Furthermore, according to the comprehensive report, the opinions of $GeneDx Holdings (WGS.US)$'s main analysts recently are as follows:

Following GeneDx's significant third-quarter revenue surpassing expectations, recognition has been given for the company's robust growth and performance. However, the current valuation suggests a considerable premium. Revenue projections for 2024-2026 have been revised upward by 8%-9%. Additionally, credit has been attributed to the management for executing what is considered one of the industry's most remarkable and rapid transformations.
GeneDx's third-quarter report was characterized as 'another strong' performance, with an 18% revenue surplus and a raised forecast for the fiscal year's revenue. Significantly, GeneDx achieved its profitability objectives sooner than anticipated.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

富國集團分析師Brandon Couillard維持$GeneDx Holdings (WGS.US)$持有評級，並將目標價從66美元上調至75美元。

根據TipRanks數據顯示，該分析師近一年總勝率為61.9%，總平均回報率為18.0%。

AnalystRecentRatingAutoNews_83176336882815_20241029_a217f42d556d60e2dbb6108a6579d67f288a3b34_1730241055498533_mm_tc

此外，綜合報道，$GeneDx Holdings (WGS.US)$近期主要分析師觀點如下：

在基因診斷第三季度營業收入明顯超出預期之後，公司的強勁增長和業績得到認可。然而，目前的估值表明存在相當大的溢價。2024年至2026年的營業收入預測上調了8%-9%。此外，對管理層執行被認爲是行業板塊最引人注目和最迅速轉型之一表示讚賞。
基因診斷的第三季度報告被描述爲「又一次強勁」的表現，營業收入增加18%，並提高了財年營業收入預測。值得注意的是，基因診斷比預期更早實現了盈利目標。

提示:

TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。

TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。

分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。

總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息

Wells Fargo Maintains GeneDx Holdings(WGS.US) With Hold Rating, Raises Target Price to $75

Wells Fargo Maintains GeneDx Holdings(WGS.US) With Hold Rating, Raises Target Price to $75

風險及免責聲明

聲明